News Release

Printer Friendly Version View printer-friendly version
<< Back
Allscripts strengthens payer and life sciences’ focus and talent, expands capabilities
Company brings together life science industry experts to accelerate growth and focus on Late-Phase Clinical Research, Real-World Evidence data and analytics solutions  

CHICAGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX), a global leader in healthcare technology, announced that it has expanded its leadership team across product management and business development in the Payer and Life Sciences division (PLS). 

Allscripts Payer and Life Sciences division extends the company’s provider healthcare network by connecting payers, health plans, pharmaceutical and life sciences, and employers more closely to the care process. Acquisitions of Practice Fusion (a cloud-based electronic health record system) and Evalytica (a real-world analytic platform) earlier this year, coupled with recent appointments of well-known industry experts to the payer and life sciences leadership team, significantly strengthen Allscripts life sciences footprint. With these changes, the Payer and Life Sciences organization is uniquely positioned to achieve its mission of developing innovative solutions where clinical research is a natural byproduct of the care process, optimizing outcomes for all stakeholders across the care-delivery continuum.

“I'm very pleased to announce that we are bringing together established industry experts with proven records of success to accelerate growth and value to our client base,” said Tom Langan, CEO of Allscripts Payer and Life Sciences organization.

The Allscripts Payer and Life Sciences leadership team now includes:

Stephanie Reisinger, Vice President and General Manager – Reisinger is a recognized expert in life science data and analytics innovation, including leadership in the development and commercialization of innovative healthcare analytic software and Real-World Evidence data products. Most recently, Reisinger was the President of the Evalytica software subsidiary of Evidera division of Pharmaceutical Product Development, LLC (PPD).  She is leading the payer and life sciences data and analytics business team.  

Steve Chick, Vice President and General Manager – Chick has more than 30 years of life science industry experience, including previous roles as Senior Vice President role at the Syneos Health (formerly InVentiv Health), Late Phase Clinical Research Division, and running a Comprehensive Health Insights research team at Humana. He now leads the payer and life sciences clinical research business team.

Stella Chang – Executive Director – Chang brings diverse expertise to the payer and life sciences organization. Previously, she served as Vice President, health policy and data analytics at IBM Watson Health, as well as Senior Director, Truven Health Analytics, where she was responsible for the MarketScan product. She now leads the analytics product and delivery teams.

Dave DornstreichVice President Strategic Initiatives and Data Partnerships
Dornstreich has more than 20 years of life science experience, which includes roles at Precision Health AI, American College of Cardiology, and Cancer LINQ, a wholly owned subsidiary of ASCO. In his new role, he will focus on biopharma business development and engage with external organizations (medical societies, regulatory and government agencies, academic institutions, commercial organizations) to enrich and extend data content and capabilities.

About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog

© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

allscriptslogo.jpg

Stock Information

Featured Events

  Q3 2018 Earnings Press Release

  Q3 2018 - Supplemental Financial Data

Transfer Agent Info:

For questions about your shares or address changes, please
click here for more information.